Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study

Journal of Cardiology

Volumn 56, Issue 3, 2010, Pages 354-360

  Higuma, Takumi ^a   Oikawa, Koichi ^a   Kato, Takeshi ^b   Mori, Yasuhiro ^b   Kudo, Takeshi ^c   Yamamoto, Takeru ^c   Hoshi, Yoshiki ^d   Kameda, Kunihiko ^d   Suto, Naoyuki ^e   Fujita, Norio ^f   Inokubo, Yoichi ^g   Konta, Atsushi ^h   Osanai, Tomohiro ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Aomori City Hospital   (Japan)

^c Goshogawara Seihoku Chuoh Hospital   (Japan)

^d Misawa City Hospital   (Japan)

^e AOMORI ROSAI HOSPITAL   (Japan)

^f Mutsu General Hospital   (Japan)

^g Hachinohe City Hospital   (Japan)

^h AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Calcium antagonists; Diltiazem R; Nifedipine CR; Vasospastic angina

Indexed keywords

ACETYLCHOLINE; ANTIANGINA PECTORIS AGENT; DILTIAZEM; GLYCERYL TRINITRATE; NICORANDIL; NIFEDIPINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATRIOVENTRICULAR BLOCK; BEDTIME DOSAGE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SPASM; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART PALPITATION; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MORNING DOSAGE; PROSPECTIVE STUDY; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NIFEDIPINE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 78049429551     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.07.010     Document Type: Article

References (25)

1. Pristipino C., Beltrame J.F., Finocchiaro M.L., Hattori R., Fujita M., Mongiardo R., Cianflone D., Sanna T., Sasayama S., Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000, 101:1102-1108.
2. Oliva P.B., Potts D.E., Pluss R.G. Coronary artery spasm in Prinzmetal angina: documentation by coronary angiography. N Engl J Med 1973, 288:745-751.
3. Yasue H., Touyama M., Shimamoto M., Kato H., Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974, 50:534-539.
4. Oliva P.B., Breckinridge J.C. Arteriographic evidence of coronary artery spasm in acute myocardial infarction. Circulation 1977, 56:366-374.
5. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A.M., Severi S., Parodi O., Biagini A., Distante A., Pesola A. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of preinfarction angina. N Engl J Med 1978, 299:1271-1277.
6. Yasue H., Omote S., Takizawa A., Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res 1983, 52(2 Pt. 2):I147-I152.
7. Yasue H., Takizawa A., Nagao M., Nishida S., Horie M., Kubota J., Omote S., Takaoka K., Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988, 78:1-9.
8. Antman E., Muller J., Goldberg S., MacAlpin R., Rubenfire M., Tabatznik B., Liang C.S., Heupler F., Achuff S., Reichek N., Geltman E., Kerin N.Z., Neff R.K., Braunwald E. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med 1980, 302:1269-1273.
9. Kimura E., Kishida H. Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 1981, 63:844-848.
10. Morikami Y., Yasue H. Efficacy of slow-release nifedipine on myocardial ischemic episodes in variant angina pectoris. Am J Cardiol 1991, 68:580-584.
11. 2006-2007 JCS Joint Working Groups Report Guidelines for diagnosis and treatment of patients with coronary spastic angina (JCS2008). Circ J 2008, 72(Suppl. 4):1195-1238.
12. Ito A., Fukumoto Y., Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004, 44:480-485.
13. Arioka I., Dohi S., Dohi S., Sakai K. Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine. Arzneimittelforschung 2008, 58:435-440.
14. Fukumoto Y., Yasuda S., Ito A., Shimokawa H. Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine. J Cardiovasc Pharmacol 2008, 51:253-257.
15. Okumura K., Yasue H., Horio Y., Takaoka K., Matsuyama K., Kugiyama K., Fujii H., Morikami Y. Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation 1988, 77:535-542.
16. Sueda S., Ochi N., Kawada H., Matsuda S., Hayashi Y., Tsuruoka T., Uraoka T. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 1999, 83:1186-1190.
17. Nakamichi N., Yanagida T., Hikima Y., Kobayashi N., Shiga K., Tsuji S., Tanaka T., Tamagawa K., Sekino H. Phase I study of nifedipine sustained-release formulation (BAY a 1040-OD tablets); single administration study. Jpn Pharmacol Ther 1995, 23(Suppl.):241-255. [in Japanese].
18. Kanazawa T., Ikeda S., Takishima T., Kariyone S., Yasui S. Clinical effect of Herbesser (CRD-401) and its sustained release preparation (TA-2006) on variant angina and rest angina-evaluation by 24-h Holter recordings. Cardioangiology 1989, 26:327-344. [in Japanese].
19. Kainuma H., Kaneda N., Hayashi M., Murata K., Mano H., Banno K., Sato T. Bioequivalence study on sustained-release diltiazem preparation. J Clin Ther Med 1996, 12:1795-1807. [in Japanese].
20. Ginsburg R., Lamb I.H., Schroeder J.S., Hu M., Harrison D.C. Randomized double-blind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm. Am Heart J 1982, 103:44-49.
21. Singh B.N. The mechanism of action of calcium antagonists relative to their clinical application. Br J Pharmacol 1986, 21(Suppl. 2):109S-121S.
22. Yasue H., Kugiyama K. Coronary spasm: clinical features and pathogenesis. Intern Med 1997, 36:760-765.
23. Oikawa Y., Matsuno S., Yajima J., Nakamura M., Ono T., Ishiwata S., Fujimoto Y., Aizawa T. Effects of treatment with once-daily nifedipine CR and twice-daily benidipine on prevention of symptomatic attacks in patients with coronary spastic angina pectoris-Adalat Trial vs. Coniel in Tokyo against Coronary Spastic Angina (ATTACK CSA). J Cardiol 2010, 55:238-247.
24. Landmark K. Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets. J Cardiovasc Pharmacol 1985, 7:12-17.
25. Minami J., Numabe A., Andoh N., Kobayashi N., Horinaka S., Ishimitsu T., Matsuoka H. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension. Br J Clin Pharmacol 2004, 57:632-639.